Trial Profile
A Randomized, Double-blind, Active Comparator, Phase I/Ⅱa Clinical Trial to Assess the Safety and Immunogenicity of the 'IL-YANG Flu Vaccine Quadrivalent Inj.' in Healthy Korean Adult Subjects
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 12 Aug 2020
Price :
$35
*
At a glance
- Drugs Il-Yang Flu vaccine quadrivalent (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- Sponsors Il-Yang
- 01 Jul 2015 New trial record